Dana M Allswede1, Stephen L Buka2, Robert H Yolken3, E Fuller Torrey4, Tyrone D Cannon5. 1. Department of Psychology, Yale University, New Haven, CT, USA. Electronic address: dana.allswede@yale.edu. 2. Department of Epidemiology, School of Public Health, Brown University, Providence, RI, USA. Electronic address: stephen_buka@brown.edu. 3. The Stanley Medical Research Institute, Chevy Chase, MD, USA. Electronic address: rhyolken@gmail.com. 4. The Stanley Medical Research Institute, Chevy Chase, MD, USA. Electronic address: torreyf@stanleyresearch.org. 5. Department of Psychology, Yale University, New Haven, CT, USA; Department of Psychiatry, Yale University, New Haven, CT, USA. Electronic address: tyrone.cannon@yale.edu.
Abstract
BACKGROUND: Pregnancy and birth complications, particularly those associated with maternal inflammation and fetal hypoxia, are associated with increased risk for schizophrenia later in life. However, the molecular mechanisms underlying these associations are not fully delineated. This study sought to examine the effect of exposure to maternal inflammation on risk of developing psychosis in adulthood. Maternal serum levels of pro-inflammatory Th1 cytokines (IL-2, interferon gamma [IFN-γ], IL-12) and Th17 cytokines (IL-1b, IL-6, IL-8, tumor necrosis factor alpha [TNF-α], granulocyte macrophage colony stimulating factor [gm-csf]) and anti-inflammatory Th2 cytokines (IL-4, IL-5, and IL-13) and Treg cytokines (IL-10) were evaluated for association with later psychosis in the offspring. METHODS: Subjects were 43 adults with psychoses and 43 matched controls followed from gestation as part of the Philadelphia cohort of the National Collaborative Perinatal Project. Adult symptoms of psychosis were assessed via medical records review and confirmed with a validation study. Archived maternal serum samples collected at the time of birth were analyzed for cytokine levels using a multiplex bead assay. RESULTS: Individuals exposed to elevated maternal levels of anti-inflammatory Th2 cytokines (≥75th percentile) were significantly less likely to develop psychosis in adulthood. CONCLUSIONS: These results may suggest that increased maternal levels of anti-inflammatory cytokines during the perinatal period could protect against the development of psychosis.
BACKGROUND: Pregnancy and birth complications, particularly those associated with maternal inflammation and fetal hypoxia, are associated with increased risk for schizophrenia later in life. However, the molecular mechanisms underlying these associations are not fully delineated. This study sought to examine the effect of exposure to maternal inflammation on risk of developing psychosis in adulthood. Maternal serum levels of pro-inflammatory Th1 cytokines (IL-2, interferon gamma [IFN-γ], IL-12) and Th17 cytokines (IL-1b, IL-6, IL-8, tumor necrosis factor alpha [TNF-α], granulocyte macrophage colony stimulating factor [gm-csf]) and anti-inflammatory Th2 cytokines (IL-4, IL-5, and IL-13) and Treg cytokines (IL-10) were evaluated for association with later psychosis in the offspring. METHODS: Subjects were 43 adults with psychoses and 43 matched controls followed from gestation as part of the Philadelphia cohort of the National Collaborative Perinatal Project. Adult symptoms of psychosis were assessed via medical records review and confirmed with a validation study. Archived maternal serum samples collected at the time of birth were analyzed for cytokine levels using a multiplex bead assay. RESULTS: Individuals exposed to elevated maternal levels of anti-inflammatory Th2 cytokines (≥75th percentile) were significantly less likely to develop psychosis in adulthood. CONCLUSIONS: These results may suggest that increased maternal levels of anti-inflammatory cytokines during the perinatal period could protect against the development of psychosis.
Authors: Faraj L Haddad; Salonee V Patel; Ella E Doornaert; Cleusa De Oliveira; Brian L Allman; Kelly J Baines; Stephen J Renaud; Susanne Schmid Journal: Brain Behav Immun Health Date: 2022-05-18
Authors: Amanda C Kentner; Staci D Bilbo; Alan S Brown; Elaine Y Hsiao; A Kimberley McAllister; Urs Meyer; Brad D Pearce; Mikhail V Pletnikov; Robert H Yolken; Melissa D Bauman Journal: Neuropsychopharmacology Date: 2018-08-21 Impact factor: 7.853
Authors: Aranyak Goswami; Frank R Wendt; Gita A Pathak; Daniel S Tylee; Flavio De Angelis; Antonella De Lillo; Renato Polimanti Journal: Front Neuroendocrinol Date: 2021-05-04 Impact factor: 8.333